LINCOLN PHARMACEUTICALS
|
LINCOLN PHARMACEUTICALS Last 5 Year Balance Sheet History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| EQUITY AND LIABILITIES | |||||
| Share Capital | ₹20 Cr | ₹20 Cr | ₹20 Cr | ₹20 Cr | ₹20 Cr |
| Equity - Authorised | ₹32 Cr | ₹32 Cr | ₹32 Cr | ₹32 Cr | ₹32 Cr |
| Equity - Issued | ₹20 Cr | ₹20 Cr | ₹20 Cr | ₹20 Cr | ₹20 Cr |
| Equity Paid Up | ₹20 Cr | ₹20 Cr | ₹20 Cr | ₹20 Cr | ₹20 Cr |
| Equity Shares Forfeited | - | - | - | - | - |
| Adjustments to Equity | - | - | - | - | - |
| Preference Capital Paid Up | - | - | - | - | - |
| Face Value | ₹10.00 | ₹10.00 | ₹10.00 | ₹10.00 | ₹10.00 |
| Share Warrants & Outstandings | - | - | - | - | - |
| Total Reserves | ₹652 Cr | ₹573 Cr | ₹482 Cr | ₹413 Cr | ₹346 Cr |
| Securities Premium | ₹65 Cr | ₹65 Cr | ₹65 Cr | ₹65 Cr | ₹65 Cr |
| Capital Reserves | ₹-9.59 Cr | ₹-9.59 Cr | ₹-9.59 Cr | ₹-9.59 Cr | ₹-9.59 Cr |
| Profit & Loss Account Balance | ₹586 Cr | ₹507 Cr | ₹418 Cr | ₹348 Cr | ₹282 Cr |
| General Reserves | ₹11 Cr | ₹11 Cr | ₹10 Cr | ₹9.74 Cr | ₹9.24 Cr |
| Other Reserves | ₹-0.33 Cr | ₹-0.42 Cr | ₹-0.48 Cr | ₹-0.18 Cr | ₹-0.31 Cr |
| Reserve excluding Revaluation Reserve | ₹652 Cr | ₹573 Cr | ₹482 Cr | ₹413 Cr | ₹346 Cr |
| Revaluation reserve | - | - | - | - | - |
| Shareholder's Funds | ₹672 Cr | ₹593 Cr | ₹502 Cr | ₹433 Cr | ₹366 Cr |
| Minority Interest | - | - | - | - | - |
| Long-Term Borrowings | - | - | - | - | - |
| Secured Loans | - | - | - | - | ₹0.15 Cr |
| Non Convertible Debentures | - | - | - | - | - |
| Converible Debentures & Bonds | - | - | - | - | - |
| Packing Credit - Bank | - | - | - | - | - |
| Inter Corporate & Security Deposit | - | - | - | - | - |
| Term Loans - Banks | - | - | - | - | - |
| Term Loans - Institutions | - | - | - | - | - |
| Other Secured | - | - | - | - | ₹0.15 Cr |
| Unsecured Loans | - | - | - | - | - |
| Fixed Deposits - Public | - | - | - | - | - |
| Loans and advances from subsidiaries | - | - | - | - | - |
| Inter Corporate Deposits (Unsecured) | - | - | - | - | - |
| Foreign Currency Convertible Notes | - | - | - | - | - |
| Long Term Loan in Foreign Currency | - | - | - | - | - |
| Loans - Banks | - | - | - | - | - |
| Loans - Govt. | - | - | - | - | - |
| Loans - Others | - | - | - | - | - |
| Other Unsecured Loan | - | - | - | - | - |
| Deferred Tax Assets / Liabilities | ₹13 Cr | ₹11 Cr | ₹7.94 Cr | ₹6.46 Cr | ₹5.69 Cr |
| Deferred Tax Assets | ₹1.19 Cr | ₹0.93 Cr | ₹0.71 Cr | ₹0.47 Cr | ₹0.77 Cr |
| Deferred Tax Liability | ₹14 Cr | ₹12 Cr | ₹8.65 Cr | ₹6.93 Cr | ₹6.46 Cr |
| Other Long Term Liabilities | ₹5.39 Cr | ₹3.63 Cr | ₹4.72 Cr | ₹4.54 Cr | ₹4.29 Cr |
| Long Term Trade Payables | - | - | - | - | - |
| Long Term Provisions | ₹0.73 Cr | ₹0.10 Cr | ₹25 Cr | - | ₹16 Cr |
| Total Non-Current Liabilities | ₹19 Cr | ₹15 Cr | ₹38 Cr | ₹11 Cr | ₹26 Cr |
| Current Liabilities | - | - | - | - | - |
| Trade Payables | ₹85 Cr | ₹72 Cr | ₹51 Cr | ₹72 Cr | ₹57 Cr |
| Sundry Creditors | ₹85 Cr | ₹72 Cr | ₹51 Cr | ₹72 Cr | ₹57 Cr |
| Acceptances | - | - | - | - | - |
| Due to Subsidiaries- Trade Payables | - | - | - | - | - |
| Other Current Liabilities | ₹15 Cr | ₹15 Cr | ₹15 Cr | ₹9.84 Cr | ₹13 Cr |
| Bank Overdraft / Short term credit | - | - | - | - | - |
| Advances received from customers | ₹3.39 Cr | ₹1.32 Cr | ₹0.82 Cr | ₹0.11 Cr | ₹3.54 Cr |
| Interest Accrued But Not Due | - | - | - | - | - |
| Share Application Money | - | - | - | - | - |
| Current maturity of Debentures & Bonds | - | - | - | - | - |
| Current maturity - Others | - | - | - | - | - |
| Other Liabilities | ₹11 Cr | ₹14 Cr | ₹14 Cr | ₹9.73 Cr | ₹9.89 Cr |
| Short Term Borrowings | - | ₹1.07 Cr | ₹2.00 Cr | ₹2.04 Cr | - |
| Secured ST Loans repayable on Demands | - | - | - | - | - |
| Working Capital Loans- Sec | - | - | - | - | - |
| Buyers Credits - Unsec | - | - | - | - | - |
| Commercial Borrowings- Unsec | - | - | - | - | - |
| Other Unsecured Loans | - | ₹1.07 Cr | ₹2.00 Cr | ₹2.04 Cr | - |
| Short Term Provisions | ₹31 Cr | ₹29 Cr | ₹29 Cr | ₹27 Cr | ₹24 Cr |
| Proposed Equity Dividend | - | - | - | - | - |
| Provision for Corporate Dividend Tax | - | - | - | - | - |
| Provision for Tax | ₹25 Cr | ₹25 Cr | ₹25 Cr | ₹24 Cr | ₹22 Cr |
| Provision for post retirement benefits | - | - | - | - | - |
| Preference Dividend | - | - | - | - | - |
| Other Provisions | ₹6.49 Cr | ₹3.52 Cr | ₹3.89 Cr | ₹2.66 Cr | ₹2.18 Cr |
| Total Current Liabilities | ₹131 Cr | ₹117 Cr | ₹96 Cr | ₹111 Cr | ₹95 Cr |
| Total Liabilities | ₹822 Cr | ₹725 Cr | ₹637 Cr | ₹555 Cr | ₹487 Cr |
| ASSETS | |||||
| Gross Block | ₹252 Cr | ₹237 Cr | ₹197 Cr | ₹171 Cr | ₹142 Cr |
| Less: Accumulated Depreciation | ₹70 Cr | ₹57 Cr | ₹47 Cr | ₹39 Cr | ₹31 Cr |
| Less: Impairment of Assets | - | - | - | - | - |
| Net Block | ₹182 Cr | ₹179 Cr | ₹151 Cr | ₹132 Cr | ₹111 Cr |
| Lease Adjustment A/c | - | - | - | - | - |
| Capital Work in Progress | ₹4.47 Cr | ₹3.48 Cr | ₹6.71 Cr | ₹16 Cr | ₹1.69 Cr |
| Non Current Investments | ₹0.00 Cr | ₹0.00 Cr | ₹0.00 Cr | ₹0.00 Cr | ₹0.00 Cr |
| Long Term Investment | ₹0.00 Cr | ₹0.00 Cr | ₹0.00 Cr | ₹0.00 Cr | ₹0.00 Cr |
| Quoted | - | - | - | - | - |
| Unquoted | ₹0.00 Cr | ₹0.00 Cr | ₹0.00 Cr | ₹0.00 Cr | ₹0.00 Cr |
| Long Term Loans & Advances | ₹111 Cr | ₹80 Cr | ₹88 Cr | ₹32 Cr | ₹47 Cr |
| Other Non Current Assets | - | ₹0.00 Cr | ₹0.00 Cr | ₹1.75 Cr | ₹0.45 Cr |
| Total Non-Current Assets | ₹297 Cr | ₹263 Cr | ₹245 Cr | ₹182 Cr | ₹160 Cr |
| Current Assets Loans & Advances | - | - | - | - | - |
| Currents Investments | ₹174 Cr | ₹139 Cr | ₹91 Cr | ₹97 Cr | ₹81 Cr |
| Quoted | ₹34 Cr | ₹9.73 Cr | - | - | - |
| Unquoted | ₹139 Cr | ₹129 Cr | ₹91 Cr | ₹97 Cr | ₹81 Cr |
| Inventories | ₹79 Cr | ₹77 Cr | ₹70 Cr | ₹73 Cr | ₹47 Cr |
| Raw Materials | ₹29 Cr | ₹22 Cr | ₹21 Cr | ₹27 Cr | ₹18 Cr |
| Work-in Progress | ₹6.87 Cr | ₹8.28 Cr | ₹9.18 Cr | ₹8.72 Cr | ₹5.53 Cr |
| Finished Goods | ₹6.51 Cr | ₹7.61 Cr | ₹1.70 Cr | ₹2.04 Cr | ₹1.67 Cr |
| Packing Materials | ₹12 Cr | ₹8.92 Cr | ₹9.25 Cr | ₹9.82 Cr | ₹6.77 Cr |
| Stores  and Spare | - | - | - | - | - |
| Other Inventory | ₹24 Cr | ₹30 Cr | ₹29 Cr | ₹25 Cr | ₹15 Cr |
| Sundry Debtors | ₹166 Cr | ₹162 Cr | ₹136 Cr | ₹116 Cr | ₹113 Cr |
| Debtors more than Six months | ₹10 Cr | ₹12 Cr | ₹6.99 Cr | ₹4.79 Cr | ₹11 Cr |
| Debtors Others | ₹158 Cr | ₹152 Cr | ₹131 Cr | ₹113 Cr | ₹104 Cr |
| Cash and Bank | ₹22 Cr | ₹14 Cr | ₹34 Cr | ₹19 Cr | ₹14 Cr |
| Cash in hand | ₹0.50 Cr | ₹0.56 Cr | ₹0.37 Cr | ₹0.25 Cr | ₹0.34 Cr |
| Balances at Bank | ₹22 Cr | ₹13 Cr | ₹34 Cr | ₹19 Cr | ₹14 Cr |
| Other cash and bank balances | - | - | - | - | - |
| Other Current Assets | ₹2.64 Cr | ₹1.69 Cr | ₹2.10 Cr | ₹1.19 Cr | ₹1.43 Cr |
| Interest accrued on Investments | - | - | - | - | - |
| Interest accrued on Debentures | - | - | - | - | - |
| Deposits with Government | - | - | - | - | - |
| Interest accrued and or due on loans | ₹0.17 Cr | ₹0.06 Cr | ₹0.14 Cr | ₹0.34 Cr | ₹0.21 Cr |
| Prepaid Expenses | ₹1.81 Cr | ₹1.63 Cr | ₹1.94 Cr | ₹0.37 Cr | ₹1.14 Cr |
| Other current_assets | ₹0.66 Cr | - | ₹0.03 Cr | ₹0.48 Cr | ₹0.09 Cr |
| Short Term Loans and Advances | ₹81 Cr | ₹70 Cr | ₹57 Cr | ₹68 Cr | ₹72 Cr |
| Advances recoverable in cash or in kind | ₹7.44 Cr | ₹4.34 Cr | ₹2.10 Cr | ₹2.57 Cr | ₹15 Cr |
| Advance income tax and TDS | ₹26 Cr | ₹25 Cr | ₹24 Cr | ₹20 Cr | ₹19 Cr |
| Amounts due from directors | - | - | - | - | - |
| Due From Subsidiaries | - | - | - | - | - |
| Inter corporate deposits | - | - | - | - | - |
| Corporate Deposits | - | - | - | - | - |
| Other Loans & Advances | ₹48 Cr | ₹40 Cr | ₹31 Cr | ₹45 Cr | ₹37 Cr |
| Total Current Assets | ₹525 Cr | ₹463 Cr | ₹391 Cr | ₹373 Cr | ₹328 Cr |
| Net Current Assets (Including Current Investments) | ₹394 Cr | ₹346 Cr | ₹295 Cr | ₹262 Cr | ₹233 Cr |
| Miscellaneous Expenses not written off | - | - | - | - | - |
| Total Assets | ₹822 Cr | ₹725 Cr | ₹637 Cr | ₹555 Cr | ₹487 Cr |
| Contingent Liabilities | ₹3.12 Cr | ₹0.23 Cr | ₹0.23 Cr | ₹0.23 Cr | ₹1.46 Cr |
| Total Debt | - | ₹1.07 Cr | ₹2.00 Cr | ₹2.04 Cr | ₹0.52 Cr |
| Book Value | - | 295.98 | 250.86 | 216.12 | 182.92 |
| Adjusted Book Value | 335.34 | 295.98 | 250.86 | 216.12 | 182.92 |
Compare Balance Sheet of peers of LINCOLN PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LINCOLN PHARMACEUTICALS | ₹950.0 Cr | -1% | -6% | -49.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹430,513.0 Cr | -0.1% | 3.4% | -0.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹170,614.0 Cr | 1.6% | -2.5% | 8.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹128,245.0 Cr | 0.8% | -0.9% | 13.5% | Stock Analytics | |
| CIPLA | ₹122,555.0 Cr | 1.3% | -0.6% | 3.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,803.0 Cr | 1% | 3.7% | 2.7% | Stock Analytics | |
LINCOLN PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LINCOLN PHARMACEUTICALS | -1% |
-6% |
-49.7% |
| SENSEX | -0.5% |
1% |
4.6% |
You may also like the below Video Courses